(FG) F&G Annuities & Life - Overview
Stock: Annuities, Life Insurance, Pension Transfer, Funding Agreements
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.64% |
| Yield on Cost 5y | 5.87% |
| Yield CAGR 5y | 5.99% |
| Payout Consistency | 100.0% |
| Payout Ratio | 49.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.3% |
| Relative Tail Risk | -2.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -48.92 |
| Character TTM | |
|---|---|
| Beta | 0.838 |
| Beta Downside | 0.945 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.06% |
| CAGR/Max DD | 0.20 |
Description: FG F&G Annuities & Life January 10, 2026
F&G Annuities & Life, Inc. (NYSE:FG) and its subsidiaries sell a suite of annuity and life-insurance products in the U.S., including fixed-indexed, index-linked, and multi-year guarantee annuities, immediate annuities, indexed universal life policies, pension-risk-transfer solutions, and institutional funding agreements. Distribution is handled through independent agents, banks, and broker-dealers serving both retail and institutional clients. The firm was founded in 1959, is headquartered in Des Moines, Iowa, and operates as a subsidiary of Fidelity National Financial, Inc.
Key identifiers: ticker FG, common stock, U.S.-based, classified under the GICS sub-industry “Life & Health Insurance.”
Recent performance metrics (FY 2023) show $1.2 billion in total assets under management and a net income of $84 million, yielding a return on equity of roughly 7.5 %. The company’s combined ratio for its life-insurance segment has hovered around 95 %, indicating modest underwriting profitability. Core economic drivers include the aging U.S. population (≈ 16 % over 65, projected to rise to 22 % by 2035) and the prevailing low-interest-rate environment, which compresses margins on fixed-income-linked annuities but boosts demand for indexed and guarantee products.
For a deeper, data-rich assessment of FG’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 464.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -3.16 > 1.0 |
| NWC/Revenue: 802.8% < 20% (prev 756.2%; Δ 46.61% < -1%) |
| CFO/TA 0.05 > 3% & CFO 4.83b > Net Income 464.0m |
| Net Debt (55.0m) to EBITDA (1.38b): 0.04 < 3 |
| Current Ratio: 4.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.0m) vs 12m ago 12.10% < -2% |
| Gross Margin: 30.70% > 18% (prev 0.18%; Δ 3052 % > 0.5%) |
| Asset Turnover: 5.80% > 50% (prev 6.54%; Δ -0.74% > 0%) |
| Interest Coverage Ratio: 4.57 > 6 (EBITDA TTM 1.38b / Interest Expense TTM 161.0m) |
Altman Z'' 3.02
| A: 0.44 (Total Current Assets 53.79b - Total Current Liabilities 11.79b) / Total Assets 96.14b |
| B: 0.03 (Retained Earnings 2.48b / Total Assets 96.14b) |
| C: 0.01 (EBIT TTM 735.0m / Avg Total Assets 90.13b) |
| D: 0.01 (Book Value of Equity 1.10b / Total Liabilities 91.20b) |
| Altman-Z'' Score: 3.02 = A |
Beneish M -4.00
| DSRI: 1.43 (Receivables 16.91b/12.41b, Revenue 5.23b/5.50b) |
| GMI: 0.60 (GM 30.70% / 18.30%) |
| AQI: -11.00 (AQ_t 0.44 / AQ_t-1 -0.04) |
| SGI: 0.95 (Revenue 5.23b / 5.50b) |
| TATA: -0.05 (NI 464.0m - CFO 4.83b) / TA 96.14b) |
| Beneish M-Score: -10.23 (Cap -4..+1) = AAA |
What is the price of FG shares?
Over the past week, the price has changed by -3.76%, over one month by -1.77%, over three months by -4.29% and over the past year by -33.96%.
Is FG a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 12.8% |
| Analysts Target Price | 32 | 12.8% |
| ValueRay Target Price | 27.4 | -3.5% |
FG Fundamental Data Overview February 04, 2026
P/E Forward = 4.8638
P/S = 0.7213
P/B = 0.8204
Revenue TTM = 5.23b USD
EBIT TTM = 735.0m USD
EBITDA TTM = 1.38b USD
Long Term Debt = 2.24b USD (from longTermDebt, last quarter)
Short Term Debt = 302.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.0m USD (from netDebt column, last quarter)
Enterprise Value = 4.06b USD (4.01b + Debt 2.24b - CCE 2.19b)
Interest Coverage Ratio = 4.57 (Ebit TTM 735.0m / Interest Expense TTM 161.0m)
EV/FCF = 0.84x (Enterprise Value 4.06b / FCF TTM 4.82b)
FCF Yield = 118.5% (FCF TTM 4.82b / Enterprise Value 4.06b)
FCF Margin = 92.07% (FCF TTM 4.82b / Revenue TTM 5.23b)
Net Margin = 8.87% (Net Income TTM 464.0m / Revenue TTM 5.23b)
Gross Margin = 30.70% ((Revenue TTM 5.23b - Cost of Revenue TTM 3.62b) / Revenue TTM)
Gross Margin QoQ = 26.33% (prev 23.85%)
Tobins Q-Ratio = 0.04 (Enterprise Value 4.06b / Total Assets 96.14b)
Interest Expense / Debt = 1.87% (Interest Expense 42.0m / Debt 2.24b)
Taxrate = 8.40% (11.0m / 131.0m)
NOPAT = 673.3m (EBIT 735.0m * (1 - 8.40%))
Current Ratio = 4.56 (Total Current Assets 53.79b / Total Current Liabilities 11.79b)
Debt / Equity = 0.47 (Debt 2.24b / totalStockholderEquity, last quarter 4.82b)
Debt / EBITDA = 0.04 (Net Debt 55.0m / EBITDA 1.38b)
Debt / FCF = 0.01 (Net Debt 55.0m / FCF TTM 4.82b)
Total Stockholder Equity = 4.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.51% (Net Income 464.0m / Total Assets 96.14b)
RoE = 10.56% (Net Income TTM 464.0m / Total Stockholder Equity 4.39b)
RoCE = 11.09% (EBIT 735.0m / Capital Employed (Equity 4.39b + L.T.Debt 2.24b))
RoIC = 10.18% (NOPAT 673.3m / Invested Capital 6.61b)
WACC = 6.39% (E(4.01b)/V(6.25b) * Re(9.0%) + D(2.24b)/V(6.25b) * Rd(1.87%) * (1-Tc(0.08)))
Discount Rate = 9.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.88%
[DCF Debug] Terminal Value 86.71% ; FCFF base≈5.64b ; Y1≈6.96b ; Y5≈11.85b
Fair Price DCF = 2198 (EV 296.00b - Net Debt 55.0m = Equity 295.95b / Shares 134.6m; r=6.39% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.60 | EPS CAGR: -8.95% | SUE: -1.46 | # QB: 0
Revenue Correlation: 37.94 | Revenue CAGR: 1.39% | SUE: 0.91 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.29 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=5.67 | Chg30d=+0.021 | Revisions Net=+1 | Growth EPS=+45.0% | Growth Revenue=+13.4%